
Italgas closed at €8.948 after the Q3 2026 numbers hit the tape, with the stock barely budging over the past week. The headline story is not the price. The real action sits in earnings power and what that implies for a heavily regulated utility with a long investment cycle.
The freshest quarter shows basic earnings per share of €0.176 on revenue of €657.5m, while trailing 12 month profit reaches €722.5m. That profit base, combined with a P/E of about 12.6x and a 4.83% dividend yield, puts the focus firmly on valuation strain versus balance sheet risk rather than short term volatility.
Love the regulated income and 4.83% yield but uneasy about valuation strain and balance sheet risk? You can filter for similar utilities with stronger financial cushions and cash generation using the list of solid balance sheet and fundamentals stocks (202 results).
Ask Charlie what makes Italgas look undervalued today.
The bullish story hangs on Italgas turning policy momentum and grid upgrades into higher quality earnings, not just bigger spend.
"Secular policy support for renewable gases and efficiency, with REPowerEU targets for biomethane, hydrogen and energy efficiency, together with Italgas’ growing biomethane connections, reverse flow investments and hydrogen pilots, could translate into higher allowed returns on green CapEx and incremental RAB growth, lifting long term revenue visibility and earnings and making a flat share price inconsistent with the improving fundamentals."
Q3 shows €657.5m of revenue and €178.8m of underlying quarterly profit, with trailing profit of €722.5m. Biomethane capacity expansion and the Floene deal indicate tangible progress on green and regulated footprints, consistent with that thesis.
On the risk side, the question is whether heavy spending and M&A start to bite into profitability or regulatory comfort.
"Execution risk on a large capex programme, where cost overruns, delays or poor integration of acquisitions could compress margins and cash flow."
Reported Q3 earnings per share of €0.176 on broadly stable underlying quarterly profit suggest no evident margin squeeze yet. Trailing profit of €722.5m against an active investment pipeline and the pending Floene acquisition points to execution that is at least keeping earnings intact rather than eroding them in this period.
Not everyone reads the same price the same way. → See the higher figure this Narrative lands on, and how it gets there.
Italgas shows how a steady quarter and a flat share price can still leave investors debating the story. The real opportunity could sit in stocks that could be undervalued before the market corrects them.
That is three of the list. See every one of the 201 undervalued companies on it →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com